In vitro neurotoxicity of amyloid β-peptide cross-linked by transglutaminase.

Cytotechnology
R ShinagawaK Takahata

Abstract

Transglutaminase catalyzes the intermolecular cross-linking of peptides between Gln and Lys residues, forming an ε-(γ-glutamyl) lysine bond. Amyloid β-peptide, a major constituent of the deposits in Alzheimer disease, contains Lys16, Lys28, and Gln15 which may act as substrates of transglutaminase. Transglutaminase treatment of amyloid β-peptide (1-28) and amyloid β-peptide (1-40) yielded cross-linked oligomers. Transglutaminase-treated Aβ retarded neurite extension of PC12 cells, and rat cultured neurons of hippocampus and septum, brain areas severely affected by Alzheimer disease, and subsequently caused cell death, whereas the transglutaminase-untreated counterparts did not show harmful effects. The transglutaminase-catalyzed oligomers of amyloid β-peptide and their neurotoxicity may be involved in two characteristics in Alzheimer disease, neuronal degeneration and formation of the insoluble deposits. AD - Alzheimer disease, Aβ - amyloid β-peptide, DMEM - Dulbecco's modified Eagle's medium, DMEM/F-12-1:1 mixture of DMEM and Ham's F-12 medium, FCS - fetal calf serum, HS - horse serum, PAGE - polyacrylamide gel electrophoresis, MTT - 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, NGF - nerve growth factor, TGase...Continue Reading

References

Jul 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·L A Greene, A S Tischler
Jul 31, 1992·Biochemical and Biophysical Research Communications·C BehlD Schubert
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M F KnauerC G Glabe
Feb 12, 1988·Cell·G G Glenner
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D A KirschnerD J Selkoe
Jan 1, 1984·Molecular and Cellular Biochemistry·L Lorand, S M Conrad
May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Oct 1, 1993·Trends in Neurosciences·M Mullan, F Crawford
Sep 1, 1993·Trends in Biochemical Sciences·F FacchianoA Luini
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·A Lorenzo, B A Yankner
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·K HensleyD A Butterfield
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·M P VitekA Cerami
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·M A SmithG Perry
Aug 29, 2012·Biochemical and Biophysical Research Communications·George G Glenner, Caine W Wong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.